20-62956835-A-G

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_022082.4(SLC17A9):​c.130A>G​(p.Met44Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,460,984 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 34)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

SLC17A9
NM_022082.4 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.66

Publications

0 publications found
Variant links:
Genes affected
SLC17A9 (HGNC:16192): (solute carrier family 17 member 9) This gene encodes a member of a family of transmembrane proteins that are involved in the transport of small molecules. The encoded protein participates in the vesicular uptake, storage, and secretion of adenoside triphosphate (ATP) and other nucleotides. A mutation in this gene was found in individuals with autosomal dominant disseminated superficial actinic porokeratosis-8. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014]
SLC17A9 Gene-Disease associations (from GenCC):
  • disseminated superficial actinic porokeratosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • porokeratosis 8, disseminated superficial actinic type
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.20892912).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC17A9NM_022082.4 linkc.130A>G p.Met44Val missense_variant Exon 2 of 13 ENST00000370351.9 NP_071365.4 Q9BYT1-1
SLC17A9NM_001302643.2 linkc.112A>G p.Met38Val missense_variant Exon 3 of 14 NP_001289572.2 Q9BYT1-2H0UI90
SLC17A9XR_936601.4 linkn.252A>G non_coding_transcript_exon_variant Exon 2 of 10
SLC17A9XM_011528978.3 linkc.-205A>G upstream_gene_variant XP_011527280.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC17A9ENST00000370351.9 linkc.130A>G p.Met44Val missense_variant Exon 2 of 13 1 NM_022082.4 ENSP00000359376.4 Q9BYT1-1
SLC17A9ENST00000370349.7 linkc.112A>G p.Met38Val missense_variant Exon 3 of 14 1 ENSP00000359374.3 Q9BYT1-2
SLC17A9ENST00000411611.1 linkc.190A>G p.Met64Val missense_variant Exon 2 of 3 2 ENSP00000388215.1 Q5W197
SLC17A9ENST00000488738.5 linkn.250A>G non_coding_transcript_exon_variant Exon 2 of 11 2

Frequencies

GnomAD3 genomes
Cov.:
34
GnomAD4 exome
AF:
0.00000137
AC:
2
AN:
1460984
Hom.:
0
Cov.:
78
AF XY:
0.00000138
AC XY:
1
AN XY:
726820
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86250
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.00000180
AC:
2
AN:
1111952
Other (OTH)
AF:
0.00
AC:
0
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
34

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Feb 08, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.130A>G (p.M44V) alteration is located in exon 2 (coding exon 2) of the SLC17A9 gene. This alteration results from a A to G substitution at nucleotide position 130, causing the methionine (M) at amino acid position 44 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.083
T
BayesDel_noAF
Benign
-0.36
CADD
Benign
5.3
DANN
Benign
0.46
DEOGEN2
Benign
0.22
T;.;.
Eigen
Benign
-0.81
Eigen_PC
Benign
-0.78
FATHMM_MKL
Benign
0.73
D
LIST_S2
Benign
0.80
T;T;T
M_CAP
Benign
0.034
D
MetaRNN
Benign
0.21
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.4
L;.;.
PhyloP100
2.7
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-1.9
N;N;N
REVEL
Benign
0.16
Sift
Benign
0.12
T;T;T
Sift4G
Benign
0.38
T;T;T
Polyphen
0.022
B;B;.
Vest4
0.21
MutPred
0.61
Loss of helix (P = 0.1299);.;.;
MVP
0.11
MPC
0.46
ClinPred
0.15
T
GERP RS
0.92
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.13
gMVP
0.52
Mutation Taster
=83/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

hg19: chr20-61588187; API